Company Profiles

driven by the PitchBook Platform

Actavalon

Description

Developer of anti-cancer drugs. The company specializes in developing proprietary broad spectrum anti-cancer drugs.

2013

Founded

PRIVATE

Status

Angel

Latest Deal Type

$529k

Latest Deal Amount

$529k

Total Amount Raised

Description

Developer of anti-cancer drugs. The company specializes in developing proprietary broad spectrum anti-cancer drugs.

Website:

www.actavalon.com

Ownership Status

Privately held (backing)

Financing Status

Angel-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

226 Jasmine Avenue Corona del Mar, CA 92625United States +1 (949) 244-5684
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Actavalon's full profile, request a free trial.

    Actavalon Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Actavalon Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Wesley Hatfield Ph.DCo-Founder, Board of Director, President & Chief Executive Officer
    Ned IsraelsenExecutive Officer & Board Member
    Van HaynieSecretary & Board Member
    Wesley Hatfield Ph.D Co-Founder, Board of Director, President & Chief Executive Officer
    Ned Israelsen Executive Officer & Board Member
    Van Haynie Secretary & Board Member

    Actavalon Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    Ned IsraelsenActavalonExecutive Officer & Board Member000 0000
    Van HaynieActavalonSecretary & Board Member000 0000
    Wesley Hatfield Ph.DActavalonCo-Founder, Board of Director, President & Chief Executive Officer000 0000
    Ned Israelsen Executive Officer & Board Member Actavalon
    Van Haynie Secretary & Board Member Actavalon
    Wesley Hatfield Ph.D Co-Founder, Board of Director, President & Chief Executive Officer Actavalon
    Request full access to PitchBook